News | August 03, 2023
Supriya Lifescience collaborates with Plasma Nutrition for protein technology
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
With an annual revenue of about $500 million, Spectrum will become part of the Industrial Solutions line of business within the Electronics & Industrial segment
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Take proper precautions and seek timely treatment!
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
Subscribe To Our Newsletter & Stay Updated
